Table 2. The relative contents of 45 identified cis-diol-containing compounds in urines of 3 types of cancer patients over healthy controls.

Identified cis-diol-containing compounds		Content ratios (vs Healthy controls)
		Lung cancer	Colorectal cancer	Nasopharyngeal cancer
1	5-Methyluridine	0.69 ± 0.03	0.52 ± 0.06	0.53 ± 0.04
2	6-Methyluridine	0.81 ± 0.07	0.40 ± 0.05	0.42 ± 0.04
3	Adenosine	0.99 ± 0.13	1.07 ± 0.02	1.28 ± 0.07
4	1-Methylguanosine	1.16 ± 0.01	1.40 ± 0.14	1.58 ± 0.07
5	Guanosine	2.08 ± 0.04	0.89 ± 0.00	1.98 ± 0.22
6	1-Methylinosine	1.80 ± 0.16	1.41 ± 0.10	1.92 ± 0.06
7	1-Methyladenosine	0.74 ± 0.05	3.77 ± 0.29	0.94 ± 0.07
8	N2-methylguanosine	1.33 ± 0.16	1.38 ± 0.09	1.43 ± 0.09
9	N2, N2-dimethylguanosine	1.32 ± 0.09	1.23 ± 0.16	1.57 ± 0.10
10	3-Methyluridine	0.72 ± 0.05	0.91 ± 0.15	1.14 ± 0.11
11	5′-Deoxy-5′-methylthioadensine	2.04 ± 0.14	3.26 ± 0.32	2.38 ± 0.32
12	Succinyladenosine	0.89 ± 0.03	0.74 ± 0.08	0.99 ± 0.07
13	N6-methyladenosine	1.27 ± 0.06	1.27 ± 0.02	1.78 ± 0.15
14	Orotidine	0.85 ± 0.07	0.78 ± 0.04	0.83 ± 0.08
15	Urate-3-ribonucleoside	1.12 ± 0.11	1.21 ± 0.05	1.09 ± 0.12
16	Nicotinamide riboside	0.69 ± 0.04	1.16 ± 0.05	1.22 ± 0.10
17	n-Ribosylhistidine	0.81 ± 0.05	0.83 ± 0.05	0.75 ± 0.01
18	Cytidine	1.29 ± 0.13	1.28 ± 0.08	1.28 ± 0.09
19	Pseudouridine	1.37 ± 0.11	1.13 ± 0.04	1.37 ± 0.17
20	Uridine	1.06 ± 0.06	1.24 ± 0.06	1.10 ± 0.06
21	5-Carbamoylmethyluridine	0.76 ± 0.03	0.72 ± 0.02	0.73 ± 0.06
22	6-Hydroxyl-1,6-dihydropurine ribonucleoside	0.75 ± 0.04	1.52 ± 0.09	1.29 ± 0.05
23	1-Methyl-N2-ethylguanosine	0.73 ± 0.10	0.51 ± 0.02	0.75 ± 0.10
24	5,6-Dihydrouridine	0.53 ± 0.07	1.25 ± 0.12	0.75 ± 0.08
25	5-Methylcytidine	1.26 ± 0.07	0.56 ± 0.04	0.55 ± 0.05
26	Inosine	1.27 ± 0.13	1.26 ± 0.11	1.24 ± 0.01
27	Ribosylpyridinonecarboxamide	1.44 ± 0.11	1.61 ± 0.09	1.88 ± 0.10
28	Xanthosine	1.62 ± 0.13	1.42 ± 0.13	2.14 ± 0.14
29	8-Oxo-Guanosine	0.58 ± 0.01	1.25 ± 0.02	1.11 ± 0.05
30	3-Methylcytidine	1.29 ± 0.16	2.11 ± 0.21	0.95 ± 0.11
31	5-Methylaminomethyluridine	1.55 ± 0.15	1.05 ± 0.08	0.75 ± 0.09
32	5′-Deoxyadenosine	1.06 ± 0.09	1.07 ± 0.14	0.77 ± 0.10
33	3-Hydroxychavicol 1-glucoside	1.26 ± 0.10	1.31 ± 0.07	1.64 ± 0.12
34	5-Methylaminomethyl-2-thiouridine	1.39 ± 0.11	0.48 ± 0.05	0.005 ± 0.00
35	Uracil-5-oxyacetic acid methylester	1.75 ± 0.04	1.38 ± 0.14	1.82 ± 0.22
36	N4-acetylcytidine	1.61 ± 0.17	1.56 ± 0.20	1.87 ± 0.17
37	1-Ribosyl-N-acetylhistamine	2.39 ± 0.15	0.09 ± 0.01	0.16 ± 0.02
38	N6-threonylcarbamoyladenosine	0.57 ± 0.04	1.00 ± 0.05	1.11 ± 0.03
39	N6-Methyl-2-methylthioadenosine	0.98 ± 0.03	0.84 ± 0.07	1.11 ± 0.02
40	7-Methylguanosine	2.34 ± 0.07	0.55 ± 0.04	2.05 ± 0.27
41	4-((1H-imidazol-2-yl)methyl)phenol-1-glucoside	9.49 ± 1.19	0.50 ± 0.02	0.12 ± 0.01
42	N6-isopentenyladenosine	25.04 ± 2.18	1.01 ± 0.01	0.85 ± 0.06
43	N2,N2,7-trimethylguanosine	1.61 ± 0.15	1.71 ± 0.15	1.55 ± 0.19
44	N2,7-dimethylguanosine	0.72 ± 0.08	0.71 ± 0.07	0.90 ± 0.12
45	1-Ribosyl-N-propionylhistamine	8.90 ± 0.97	1.51 ± 0.17	3.54 ± 0.35